Compare Humana Inc (HUM) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Unilever plc — how do they compare? Humana Inc trades at $405.62 (market cap $47.81B), while Unilever plc trades at $60.99 (market cap $131.86B). The key difference: Unilever plc is far larger — about 2.8× Humana Inc's market cap, and Unilever plc pays the higher dividend (3.68%). Which is the better fit depends on your goals.
| HUM | UL | |
|---|---|---|
Market Cap | $47.81B | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $409.42 | $74.59 |
52-Week Low | $163.67 | $55.05 |
Enterprise Value | $56.85B | $157.31B |
Dividend Yield | 0.89% | 3.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $398.09, down 0.48% with a bullish technical signal from moving averages. The company shows strong revenue growth to $129.66B in 2025 but faces margin compression with net income margin declining to 0.82%. Recent earnings have consistently beaten expectations, and analyst sentiment is mixed with 34% buy ratings but a consensus price target of $354.33 below current levels.
The outlook suggests cautious optimism with Medicare Advantage expansion opportunities but significant margin pressure and regulatory risks. Key investment considerations include the company's ability to achieve its 3% Medicare Advantage margin target by 2028 while navigating increased healthcare utilization costs and competitive pressures in the insurance sector.
Unilever (UL) trades at $62.18, down 0.34% today, with a bullish technical signal from moving averages and neutral oscillators. Recent quarterly earnings missed expectations, but the company maintains strong profitability with a 46.95% gross margin and 18.75% net margin. Key developments include a pending food business divestiture to McCormick and a $270 million innovation center investment, signaling strategic focus on core brands and digital transformation.
The outlook is mixed: valuation appears fair with a P/E of 21.15, but earnings misses and competitive pressures pose risks. Analyst consensus is cautious with 51% hold ratings. Long-term opportunities lie in emerging market growth and cost efficiencies, though near-term execution and macroeconomic headwinds require monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
